Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review
Allergy2016Vol. 72(1), pp. 146–163
Citations Over TimeTop 1% of 2016 papers
Louise A. A. Gerbens, C. A. C. Prinsen, Joanne R Chalmers, Aaron M. Drucker, L.B. von Kobyletzki, Jacqueline Limpens, Helen Nankervis, Åke Svensson, Caroline B. Terwee, Mengli Zhang, Christian Apfelbacher, Phyllis I. Spuls, the Harmonising Outcome Measures for Eczema (HOME) initiative
Abstract
ISS (paediatric version), POEM, PO-SCORAD, SA-EASI and adapted SA-EASI are currently the most appropriate instruments and therefore have the potential to be recommended as core symptom instrument in future clinical trials. These findings will be utilized for the development of a core outcome set for AE.
Related Papers
- → Quality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis(2012)122 cited
- → Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial(2017)64 cited
- → Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis(2021)15 cited
- → Frequency and influence of “not relevant” responses on the Dermatology Life Quality Index among adults with atopic dermatitis(2021)9 cited
- → Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial(2018)4 cited